Register for free to
view the full innovation profile.
Technology / 15-18: Achiral Peptoids and Variations for Treating Alzheimer Disease
About
Technology / 15-18: Achiral Peptoids and Variations for Treating Alzheimer Disease Inventor: Shannon L. Servoss, Melissa A. Moss, James Phillip Turner Jr. Status: This invention is available for licensing General Description Alzheimer's disease is a devastating disease that progressively robs the memory and the mental abilities of the patient. New peptoids have been created, by the University of Arkansas, that prevent the aggregation of the beta amyloids, and may break up existing amyloids. These new peptoids may be developed into drugs, which could be administered to Alzheimer's patients to prevent further damage to their brains, and possibly even to reverse the effects of the disease. Significance: Alzheimer's disease (AD) is sixth leading cause of death in the United States and the leading form of dementia worldwide. For interested parties seeking further information, feel free to contact: Mark Allen Lanoue Technology Manager / Tech Ventures University of Arkansas (479) 575-7243 [email protected] For additional information on the research, see this article http://vpred.uark.edu/documents/techventures/tech_docs/acs_article_4-1-14.pdf
Key Benefits
Benefits: * Protease resistant * Cost-effective production * High bio availability * Flexible molecule * Low Immunogenicity
Applications
Applications: * Alzheimer's disease * All diseases associated with amyloids * Misfolding proteins * Biomarker detections for amytoid beta and Alzheimer's disease * A beta modulation * A beta inhibition * A beta aggregation reversal * Type Il Diabetes treatment * Autism treatment * Intranasal administration for neurodegenerative